190 related articles for article (PubMed ID: 7199382)
1. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing.
Levi FA; Hrushesky WJ; Blomquist CH; Lakatua DJ; Haus E; Halberg F; Kennedy BJ
Cancer Res; 1982 Mar; 42(3):950-5. PubMed ID: 7199382
[TBL] [Abstract][Full Text] [Related]
2. Circadian stage dependence of cis-diamminedichloroplatinum lethal toxicity in rats.
Hrushesky WJ; Levi FA; Halberg F; Kennedy BJ
Cancer Res; 1982 Mar; 42(3):945-9. PubMed ID: 7199381
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin urinary pharmacokinetics and nephrotoxicity: a common circadian mechanism.
Levi F; Hrushesky WJ; Borch RF; Pleasants ME; Kennedy BJ; Halberg F
Cancer Treat Rep; 1982 Nov; 66(11):1933-8. PubMed ID: 6890406
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of sodium selenite minimizes cisplatin toxicity on proximal tubules of rats.
Camargo SM; Francescato HD; Lavrador MA; Bianchi ML
Biol Trace Elem Res; 2001 Dec; 83(3):251-62. PubMed ID: 11794517
[TBL] [Abstract][Full Text] [Related]
5. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats.
Mohan IK; Khan M; Shobha JC; Naidu MU; Prayag A; Kuppusamy P; Kutala VK
Cancer Chemother Pharmacol; 2006 Dec; 58(6):802-8. PubMed ID: 16552571
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin nephrotoxicity and protection by silibinin.
Gaedeke J; Fels LM; Bokemeyer C; Mengs U; Stolte H; Lentzen H
Nephrol Dial Transplant; 1996 Jan; 11(1):55-62. PubMed ID: 8649653
[TBL] [Abstract][Full Text] [Related]
7. cis-diamminedichloroplatinum(II) nephrotoxicity: tubular function after rescue with sodium diethyldithiocarbamate in rats.
Elliott WC; Newcom SR; Houghton DC; Baines-Hunter J; Bennett WM
Cancer Res; 1983 Aug; 43(8):3759-62. PubMed ID: 6305493
[TBL] [Abstract][Full Text] [Related]
8. Changes in the structure and function of the kidney of rats chronically exposed to cadmium. I. Biochemical and histopathological studies.
Brzóska MM; Kamiński M; Supernak-Bobko D; Zwierz K; Moniuszko-Jakoniuk J
Arch Toxicol; 2003 Jun; 77(6):344-52. PubMed ID: 12799774
[TBL] [Abstract][Full Text] [Related]
9. [Studies on protective effect of selenium on the nephrotoxicity of cis-diamminedichloroplatinum (CDDP) in mice].
Araya Y
Hokkaido Igaku Zasshi; 1990 May; 65(3):245-53. PubMed ID: 2165995
[TBL] [Abstract][Full Text] [Related]
10. Nephrotoxic potential of cis-diamminedichloroplatinum and four analogs in male Fischer 344 rats.
Levine BS; Henry MC; Port CD; Richter WR; Urbanek MA
J Natl Cancer Inst; 1981 Jul; 67(1):201-6. PubMed ID: 6942191
[TBL] [Abstract][Full Text] [Related]
11. cis-Dichlorodiammineplatinum nephrotoxicity in rats of different ages.
Braunlich H; Kuo CH; Slocombe R; Hook JB
Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):279-91. PubMed ID: 6539942
[TBL] [Abstract][Full Text] [Related]
12. [Studies on nephrotoxicity of cyclosporin. 1. Nephrotoxicity in rats receiving cyclosporin].
Pak K; Tomoyoshi T; Nomura Y; Okabe T
Hinyokika Kiyo; 1987 Dec; 33(12):1966-74. PubMed ID: 3448920
[TBL] [Abstract][Full Text] [Related]
13. [Reduction of cisplatin toxicity by fosfomycin in animal models].
Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2400-7. PubMed ID: 6541892
[TBL] [Abstract][Full Text] [Related]
14. Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration.
Levi FA; Hrushesky WJ; Halberg F; Langevin TR; Haus E; Kennedy BJ
Eur J Cancer Clin Oncol; 1982 May; 18(5):471-7. PubMed ID: 6889525
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity.
Hanigan MH; Gallagher BC; Taylor PT; Large MK
Cancer Res; 1994 Nov; 54(22):5925-9. PubMed ID: 7954424
[TBL] [Abstract][Full Text] [Related]
18. Direct amifostine effect on renal tubule cells in rats.
Weichert-Jacobsen KJ; Bannowski A; Küppers F; Loch T; Stöckle M
Cancer Res; 1999 Jul; 59(14):3451-3. PubMed ID: 10416609
[TBL] [Abstract][Full Text] [Related]
19. Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 May; 358():1-142. PubMed ID: 12695783
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties.
Yuhas JM; Culo F
Cancer Treat Rep; 1980 Jan; 64(1):57-64. PubMed ID: 6247064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]